ICON PLC

Last updated
ICON plc
Company type Public
Nasdaq:  ICLR
Industry
Founded1990;34 years ago (1990) in Dublin, Ireland
Founders
  • John Climax
  • Ronan Lambe
Key people
 Steve Cutler (CEO)
ProductsServices for pharmaceutical, biotech and medical device industries
Revenue US$7.741 billion (2022) [1]
Number of employees
41,160 (2023) [1]
Website www.iconplc.com

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. [2] The company is listed on the Nasdaq stock exchange in the United States, and As of June 2023 had approximately 41,160 employees in 108 locations spread across 53 countries. [1]

Contents

History

ICON was founded in Dublin, Ireland, by John Climax and Ronan Lambe in 1990. [3] Since January 2010, Climax has held a position on the board of directors. Lambe retired from the board of directors in 2018. [4]

Between 1991 and 1996, ICON opened offices in the United Kingdom, United States, Germany, and Japan. [5] Two years later, ICON shares started to be traded on Nasdaq. [6]

In 2013, PRA Health Sciences was acquired by KKR, which listed the company on the Nasdaq in November 2014 and maintained shares until September 2019. [7] In August 2017, the company acquired Conshohocken-based real-world healthcare data, analytics, and technology solutions company Symphony Health for US$530 million. [8] PRA's 2018 revenue was US$2.87 billion. [9] PRA was acquired by ICON on 1 July 2021. [10]

In March 2017, Steve Cutler was appointed Chief Executive Officer of ICON. [11] He had previously been with Quintiles South Africa, Sandoz AG, and Kendle Intl Inc, before joining ICON Clinical Research Services in 2011, and becoming Chief Operating Officer in 2014. [12]

In 2018, ICON won PharmaTimes Clinical Researcher of the Year. [13] ICON enjoyed success in multiple categories at the Clinical Research Organisation leadership awards, [14] consecutively from 2018 - 2023, determined by Life Science Leader magazine and Industry Standard Research (ISR). In 2021, ICON was awarded PharmaTimes Clinical Research Company of the Year, [15] and in 2022, won Best Contract Research Organisation (FSP) [16] at the Scrip Awards.

Acquisitions

See also

Related Research Articles

Fresenius SE & Co. KGaA is a European multinational health care company based in Bad Homburg vor der Höhe, Germany. It provides products and services for dialysis in hospitals, as well as inpatient and outpatient medical care. The company is involved in hospital management and in engineering and services for medical centers and other health care facilities.

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

IMS Health was an American company that provided information, services and technology for the healthcare industry. IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data. IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake. In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners. The company went public on April 4, 2014, and began trading on the NYSE under the symbol IMS. IMS Health was headquartered in Danbury, Connecticut.

Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today. The company publishes the annual Parexel R&D Statistical Sourcebook and operates the Parexel-Academy.

IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).

Kantar Group Ltd. is an international market research company based in London, England. It was founded in 1992, and has approximately 30,000 employees across over 90 countries working in various research disciplines, including brand guidance, brand strategy, social media monitoring, advertising effectiveness, consumer and shopper behaviour,design strategy and public opinion.

<span class="mw-page-title-main">EXL Service</span> American multinational professional services

Exlservice Holdings, Inc. is a global analytics and digital solutions company serving industries including insurance, healthcare, banking and financial services, media, retail, and others. The company is headquartered in New York and has more than 54,000 professionals in locations throughout the United States, Europe, Asia, Latin America, Australia and South Africa.

<span class="mw-page-title-main">EPAM Systems</span> American technology company

EPAM Systems, Inc. is an American company that specializes in software engineering services, digital platform engineering, and digital product design, operating out of Newtown, Pennsylvania. EPAM is a founding member of the MACH Alliance.

Laboratory Corporation of America Holdings (Labcorp), headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.

WuXi AppTec is a global pharmaceutical, biopharmaceutical, and medical device company.

<span class="mw-page-title-main">NextGen Healthcare</span> American software and services company

NextGen Healthcare, Inc. is an American software and services company headquartered in Atlanta, Georgia. The company develops and sells electronic health record (EHR) software and practice management systems to the healthcare industry, as part of a range of software, services and analytics solutions for medical and dental practices. On September 7, 2018, Quality Systems, Inc. changed its name to NextGen Healthcare, Inc. and on September 10, their stock ticker symbol changed to NASDAQ: NXGN.

CareCloud, Inc. is a publicly traded American healthcare information technology company that provides services, to healthcare providers and hospitals. The Company maintains its headquarters in Somerset, New Jersey, and employs approximately 4,000 workers worldwide.

UDG Healthcare plc, formerly United Drug, is a Dublin-based international company and partner to the healthcare industry, providing clinical, commercial, communication and packaging services. It was listed on the London Stock Exchange until it was acquired by American private equity company Clayton, Dubilier & Rice in August 2021.

<span class="mw-page-title-main">Patterson Companies</span> Medical multinational company

Patterson Companies, Inc. provides products, technologies, services and business solutions to oral and animal health customers in North America and the U.K. The company was established in 1877 as a dental company. It entered the animal health industry in 2001 with its acquisition of Webster Veterinary and expanded with its 2015 acquisition of Animal Health International, Inc.

Medidata Solutions is an American technology company that develops and markets software as a service (SaaS) for clinical trials. These include protocol development, clinical site collaboration and management; randomization and trial supply management; capturing patient data through web forms, mobile health (mHealth) devices, laboratory reports, and imaging systems; quality monitor management; safety event capture; and monitoring and business analytics. Headquartered in New York City, Medidata has locations in China, Japan, Singapore, South Korea, the United Kingdom, and the United States.

<span class="mw-page-title-main">Evotec</span> German biopharmaceutical company

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.

Medpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 5,400 people. Medpace's mission statement is "to accelerate the global development of safe and effective medical therapeutics" through its high science and disciplined operating approach that leverages local, regulatory, and deep therapeutic expertise across all major areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Operating under a full-service model, Medpace provides a therapeutically focused, integrated, global approach to clinical development. The company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.

<span class="mw-page-title-main">PRA Health Sciences</span> Contract research company

PRA Health Sciences was a contract research organization (CRO) with headquarters in Raleigh, North Carolina. It was established in 1976 and acquired by ICON in 2021.

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States. One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. In fiscal year 2020, it generated over $3 billion in annual revenue.

References

  1. 1 2 3 "Facts and figures". ICON plc. Retrieved 2021-11-21.
  2. ↑ "ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research". www.businesswire.com. 2021-02-24. Retrieved 2021-07-01.
  3. ↑ "Icon founders poised to make $45m in share placing". Irish Times. 24 July 2003. Retrieved 8 December 2019.
  4. ↑ "Board of Directors". Red Robin Gourmet Burgers, Inc. 2023. Retrieved 2023-11-01.
  5. ↑ Langan, Sheila (1 October 2014). "ICON of Ireland". Irish America. Retrieved 8 December 2019.
  6. ↑ "ICON plc : ICON Announces the Commencement of Direct Trading on NASDAQ". Market Screener. 5 February 2013. Retrieved 8 December 2019.
  7. ↑ "PRA Health Sciences Announces Secondary Offering and Concurrent Share Repurchase". Globenewswire. September 3, 2019.
  8. ↑ Liu, Angus (August 8, 2017). "PRA Health Sciences makes $530M Symphony buy, reports 16% revenue growth in Q2". FierceBiotech.
  9. ↑ "Investors | ICON PLC".
  10. ↑ "ICON acquisition creates world-leading healthcare intelligence and clinical research organisation" (Press release). 1 July 2021.
  11. ↑ "BRIEF-ICON says Steve Cutler to be named CEO". Reuters. 20 October 2016. Retrieved 8 December 2019.
  12. ↑ "Profile Stephen A Cutler "Steve"". www.bloomberg.com. n.d. Retrieved 28 November 2021.
  13. ↑ "Winner 2018". Pharma Times. December 2018. Retrieved 8 December 2019.
  14. ↑ "ICON Wins Multiple Categories in 2019 CRO Leadership Awards". BusinessWire. 5 March 2019. Retrieved 8 December 2019.
  15. ↑ "Clinical Researcher of the Year - The Americas 2021 winners announced". Pharma Times. October 2021. Retrieved 29 October 2021.
  16. ↑ "Scrip Awards 2022 Winners have been Announced". Pharma Intelligence UK Limited. November 2022. Retrieved 30 November 2022.
  17. ↑ "YRCR was acquired by Icon on February 3, 2000". Mergr. Retrieved 8 December 2019.
  18. ↑ Barrington, Kathleen (10 June 2000). "Icon buys UCT for $2m cash plus $18m deferred payments". Independent. Retrieved 8 December 2019.
  19. ↑ McGrath, Brendan (1 February 2000). "Icon buys US data group in first public acquisition". The Irish Times. Retrieved 8 December 2019.
  20. ↑ "Form 20-F". Securities and Exchange Commission. United States Government. Retrieved 8 December 2019.
  21. ↑ "Form 20-F". Securities and Exchange Commission. United States Government. Retrieved 8 December 2019.
  22. ↑ "ICON Acquires GloboMax". Mergr. Retrieved 8 December 2019.
  23. ↑ "Beacon Bioscience Acquired by ICON July 1, 2004". Crosstree Capital. Retrieved 8 December 2019.
  24. ↑ "ICON Acquires Ovation Research Group". Mergr. Retrieved 8 December 2019.
  25. ↑ Mansell, Peter (16 July 2007). "ICON acquires clinical research staffer DOCS International". Pharma Times. Retrieved 8 December 2019.
  26. ↑ "ICON Acquires Healthcare Discoveries". Contract Pharma. 12 February 2008. Retrieved 8 December 2019.
  27. ↑ MacDonald, Gareth (22 October 2009). "Icon boosts bioanalytical presence through Prevalere buy". Outsourcing Pharma. Retrieved 8 December 2019.
  28. ↑ "ICON Acquires Veeda Laboratories Ltd". Biospace. 8 December 2008. Retrieved 8 December 2019.
  29. ↑ Rhea, Shawn (24 May 2010). "Icon acquires Timaq Medical Imaging". Modern Healthcare. Retrieved 10 December 2019.
  30. ↑ Mansell, Peter (18 January 2011). "ICON broadens late-phase expertise with Oxford Outcomes acquisition". PharmaTimes. Retrieved 10 December 2019.
  31. ↑ Lynch, Suzanne (15 July 2011). "Pharmaceutical firm Icon buys Firecrest Clinical for undisclosed sum". The Irish Times. Retrieved 10 December 2019.
  32. ↑ "ICON-PLC Acquires PriceSpective". Biospace. 28 February 2012. Retrieved 10 December 2019.
  33. ↑ "ICON Acquires BeijingWits Medical Consulting Ltd". BioSpace. 12 December 2011. Retrieved 10 December 2019.
  34. ↑ "DOCS Acquires ClinForce and Assent Consulting". DOCS Global. DOCS. Retrieved 10 December 2019.
  35. ↑ Mansell, Peter (5 February 2013). "Icon to acquire Cross Country's Clinical Trial Services Division". PharmaTimes. Retrieved 10 December 2019.
  36. ↑ Mansell, Peter (1 April 2014). "ICON to acquire Aptiv Solutions for US$143.5 million". PharmaTimes. Retrieved 10 December 2019.
  37. ↑ "ICON Completes Acquisition Of MediMedia Pharma Solutions". BioSpace. 2 March 2015. Retrieved 10 December 2019.
  38. ↑ "ICON Acquires PMG Research". Contract Pharma. 7 December 2015. Retrieved 10 December 2019.
  39. ↑ "ICON Completes the Acquisition of Clinical Research Management, Inc". BusinessWire. 19 September 2016. Retrieved 10 December 2019.
  40. ↑ "ICON Acquires Mapi Group". Health Economics. Retrieved 10 December 2019.
  41. ↑ "Symphony Clinical Research Acquired by ICON". Symphony Clinical Research. Retrieved 10 December 2019.
  42. ↑ "ICON's Acquisition of MeDiNova Research". Bloomberg. 23 May 2019. Retrieved 10 December 2019.
  43. ↑ Pennic, Fred (21 February 2019). "ICON Acquires Precision Medicine for Oncology Company MolecularMD". HIT Consultant. Retrieved 10 December 2019.
  44. ↑ "ICON Acquires MedPass International". Bloomberg. Retrieved 19 February 2020.
  45. ↑ "ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research". www.businesswire.com. 2021-02-24. Retrieved 2021-07-01.
  46. ↑ Parsons, Lucy (2021-02-26). "ICON to acquire PRA Health Sciences in $12bn deal". PharmaTimes. Retrieved 2021-10-19.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.